This inventor holds 1 USPTO granted patent. Top assignee: Inje University Industry-Academic Cooperation Foundation. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Larisa K Shubina: Innovator in Pharmaceutical Composition
Introduction
Larisa K Shubina is a prominent inventor based in Vladivostok, Russia. She has made significant contributions to the field of pharmaceutical compositions, particularly in the area of heart disease treatment. Her innovative work has led to the development of novel compounds that show promise in medical applications.
Latest Patents
Larisa holds a patent for "Neopetrosides A and B, and synthesis method thereof." This invention relates to novel pyridine nucleoside compounds, Neopetroside A (NPS A) and Neopetroside B (NPS B), which are derived from a marine sponge. The synthesis involves fractionating an extract with ethanol into n-butanol. NPS A has demonstrated the ability to activate oxidative phosphorylation and stimulate glycolysis activity in myocardial cells. Furthermore, it has shown potential in recovering left ventricular pressure in ischemic reperfusion injury models, making it a candidate for preventing or treating ischemic heart disease.
Career Highlights
Larisa is affiliated with the Inje University Industry-Academic Cooperation Foundation, where she continues her research and development efforts. Her work is characterized by a strong focus on innovative solutions for health-related issues, particularly in cardiology.
Collaborations
Larisa has collaborated with notable colleagues, including Jin Woo Han and Seung Hun Jeong, to advance her research and patent applications. These collaborations have enriched her work and contributed to the successful development of her inventions.
Conclusion
Larisa K Shubina is a trailblazer in the field of pharmaceutical innovation, with her patented compounds offering new hope for the treatment of heart disease. Her dedication to research and collaboration underscores her commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile